We are delighted to announce that the BU CTSI will support several predoctoral and postdoctoral fellows as part the CTSI training program in Regenerative Medicine. Students and Faculty interested in this support should submit the following materials by April 14, 2023. If you are interested in this support please submit an application and review the required materials and criteria […]
Take a look at Affinity Research Collaboratives’s (ARC’s) Linking Research and Researchers booklet and explore their novel interdisciplinary approaches to and impacts on both biomedical research and training.
Volume 10 │ Issue 11│ January 28, 2020 DIRECTOR’S MESSAGE Join us for virtual Rare Disease Day at NIH on Monday, March 1 to help raise awareness about rare diseases. COVID-19 pushed the scientific community – let us resolve to address research and treatments in the same way for those living with rare diseases. Read More WHAT’S […]
Please join us virtually for the 56th meeting of the National Advisory Council on Minority Health and Health Disparities! Date: Tuesday, February 2, 2021 Time: 11 a.m. – 5 p.m. ET Location: This meeting is available by NIH Videocast. The National Advisory Council on Minority Health and Health Disparities advises the Secretary of Health and […]
NIMHD Director’s Seminar Series Features L. Ebony Boulware, M.D., M.P.H on February 4 at 2:00 p.m. Attend the NIMHD Director’s Seminar Series Lecture featuring L. Ebony Boulware, M.D., M.P.H., on Thursday, February 4 at 2:00 p.m. She will discuss “Where the Cloud Meets the Ground: Democratizing Health Data to Improve Community Health Equity.” Dr. Boulware […]
Opioid addiction | Heart transplant rejection | COVID-19 immunity National Institutes of Health (NIH) sent this bulletin on 01/26/2021 02:00 PM EST COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from […]
Findings could be paradigm-shifting for cancer treatments (Boston)—Researchers from Boston University School of Medicine (BUSM) have identified proteins that are essential for the viability of whole-genome doubled tumor cells, yet non-essential to normal cells that comprise the majority of human tissue. “Exploiting these vulnerabilities represents a highly significant and currently untapped opportunity for therapeutic intervention, […]
Uses the same science as newly FDA approved COVID-19 vaccines (Boston)–When severely or chronically injured, the liver loses its ability to regenerate. A new study led by researchers at the Center for Regenerative Medicine at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) now describes a safe new potential therapeutic tool for […]
FIRST Funding Opportunities and Technical Assistance Webinar Jan. 25 The NIH-supported biomedical research workforce is more likely to thrive in environments that support diversity and inclusiveness. To this end, the NIH Common Fund is launching the Faculty Institutional Recruitment for Sustainable Transformation (FIRST) program with the goal of fostering inclusive excellence at NIH-funded institutions and […]
The “Princess Bride” Guide to Healthcare Entrepreneurship Register for our January Nexus event Overview For our first Nexus event in 2021, Lisa Suennen joins us to discuss health care venture capital. The discussion will: Disseminate key principles in launching a health care venture from the perspective of venture capitalists Discuss stages and ways to […]